Seeking Alpha
 

MetLife, Inc. (MET)

- NYSE
  • Apr. 2, 2014, 4:26 AM
    • Blackstone (BX) is reportedly in discussions to sell six office properties in the Boston area for $2.5B, with potential buyers including MetLife (MET).
    • Separately, Blackstone has agreed to acquire a 49% holding in an office property in San Francisco called One Market Plaza in a deal that values the two-tower complex at just over $1.2B. Blackstone is purchasing the stake from Paramount Group, which will continue to own the rest of the property.
    • The deal is Blackstone's second in what it considers core and core-plus real estate, which refers to low-risk, well-leased buildings in major markets that provide a stable return.
    | Comment!
  • Apr. 1, 2014, 7:20 AM
    • MetLife (MET) is up 2.3% premarket after being added to BAML's U.S. 1 list of top recommendations.
    | Comment!
  • Mar. 31, 2014, 2:55 PM
    • New York's Department of Financial Services charged MetLife (MET +0.8%) subsidiaries ALICO and DelAm with using Manhattan-based personnel to solicit business even though neither company was licensed to do so in New York. Both units were purchased from AIG in 2010, and there is an ongoing investigation of that company and the subsidiaries before the sale.
    | 2 Comments
  • Mar. 27, 2014, 2:28 PM
    • Struggling one day after the CCAR results are insurers AIG (AIG -0.9%), MetLife (MET -2.3%), and Prudential (PRU -2.6%). The group wasn't part of the CCAR process, but is potentially under the thumb of the Fed as it relates to capital returns.
    • If there is one takeaway from the CCAR, it's that the Fed - if anything - is getting even tougher with the larger institutions as it relates to capital returns. Citigroup was rejected and BofA and Goldman - facing rejection - were forced to dial back plans and resubmit their requests. "CCAR highlighted the challenges large-caps have in returning excess capital," said Goldman's Richard Ramsden earlier today.
    | Comment!
  • Mar. 25, 2014, 9:46 AM
    • "We share your frustration," writes MetLife (MET +1.2%) CEO Steve Kandarian in his letter to shareholders in the company annual report. “It is taking much longer for clarity on the capital rules than anyone had anticipated."
    • Met currently awaits word from the nation's capital on whether it will be designated a systemically important financial institution. Kandarian doesn't believe the company poses a threat to the financial system, but if it is deemed so, than the Fed should impose rules designed for insurers, not banks.
    • “If federal capital rules for life insurers do not appropriately reflect the business model of insurance, we could be forced to raise prices to consumers or exit markets entirely ... Regulators in Washington must recognize that imposing higher capital requirements on certain life insurance companies is not cost-free.”
    • Met did boost its dividend about a year ago and did buy Malaysia's AmLife and Chile's Provida, but the insurer hasn't bought back shares in a number of years.
    | Comment!
  • Mar. 19, 2014, 3:13 PM
    • A check of sectors following the FOMC statement and updated projections suggesting a quickened pace of rate hikes in the future finds the banks and life insurers notably moving higher. Both groups have struggled earning a spread amid ZIRP and are positively levered to higher rates.
    • Lenders: Bank of America (BAC +1%), Citigroup (C +1%), JPMorgan (JPM), Regions (RF +1.7%), KeyCorp (KEY +0.9%), SunTrust (STI +0.7%).
    • Life insurers: MetLife (MET +1%), Prudential (PRU +0.7%), Lincoln National (LNC +1%).
    • Related ETFs: XLF, FAS, FAZ, UYG, VFH, IYF, KIE, SEF, IYG, IAK, FXO, PFI, KBWB, FNCL, FINU, RWW, RYF, PSCF, KBWP, KBWI, FINZ, KBE, KRE
    • Not necessarily positively levered to higher rates are the mortgage REITs (REM -1.6%): Annaly (NLY -1.8%), American Capital (AGNC -1.7%), (MTGE -1.9%), Armour (ARR -1.3%), Two Harbors (TWO -2%) CYS Investments (CYS -3.3%), Capstead (CMO -1.3%), MFA (MFA -1.8%).
    • Related ETFs: MORT, MORL
    | 14 Comments
  • Mar. 18, 2014, 11:04 AM
    • Half a million doesn't buy much anymore. House Ways and Means Committee Chairman Dave Camp (R, Mich.) - a sizable recipient of Wall Street donations - has the large financial institutions displeased with his proposal to levy a tax on them. He says they deserve to pay up for the lower borrowing costs they receive because of their perceived government backstop, a notion the banks dispute.
    • The proposal is part of larger tax reform expected to get serious discussion after the mid-term elections, and a Camp spokeswoman says the overall plan will make banks "some of the biggest winners."
    • In discussions to hold a fundraiser for the NRC, Goldman Sachs (GS +0.9%) reportedly opted out over its concerns. Smaller bankers join in with their much larger brethren: "We're going to beat this like a rented mule," says Cam Fine, who heads the Independent Community Bankers Association. "This is a united effort."
    • Camp's tax would apply to financial firms with assets greater than $500B, levying a 0.035% tax on total assets each year. Among those affected (in addition to Goldman) are AIG, BAC, C, GE Capital, JPM MET, MS, PRU, and WFC. The largest could pay more than $2B per year under the plan.
    | 19 Comments
  • Mar. 11, 2014, 12:40 PM
    • The insurance industry finds an ally in Maine Senator Susan Collins who introduces an amendment to Dodd-Frank seeking to clarify new capital rules for nonbank financials.
    • Insurance companies have made the case they're not banks and already meet state-imposed leverage requirements, and thus shouldn't be subject to the same rules as banks, and the Fed - now a regulator of AIG and PRU, and maybe MET soon as well - has asked for guidance about whether Dodd-Frank allows it leeway.
    • Not a member of the Senate Banking Committee, Collins testified the Fed does indeed have flexibility and her bill seeks to make that clear.
    • Related ETFs: KIE, IAK, KBWI, KBWP
    | 1 Comment
  • Mar. 8, 2014, 9:33 AM
    • "MetLife (MET) is one of the cheaper stocks in a sector that is, itself, cheap relative to the market," says Eric Hagemann, an analyst at Richard Pzena's Penza Investment Management (an owner of the shares). A check of price/book (excluding investment gains) finds Met at 1.1x - grouped with Hartford (HIG) at 0.9x and Lincoln Financial (LNC) at 1.1x - but well less than Prudential's (PRU) 1.6x.
    • Why the discount? Met is one of few remaining large financials not yet buying back any stock as it awaits direction from D.C. (which isn't expected until late this year or early next). In same boat, AIG and Prudential have both thrown caution to the wind and begun repurchases.
    • On the other hand Met has boosted its dividend to $1.10 per share annually and the payout could approach $1.50 in 2015. There was also last year's $2B acquisition of Chilean pension fund provider Provida. If the new regulatory capital rules are too onerous, a breakup of Met into domestic and international businesses is a possibility.
    • "In a record stock market, MetLife offers a nice package for investors: a rock-bottom P/E and price/book ratio, an attractive global franchise, and a financially astute management team," writes Andrew Bary.
    | 6 Comments
  • Mar. 7, 2014, 9:42 AM
    • The life insurers open strongly in the green as interest rates shoot higher following this mornings jobs report. Up the most is Prudential (PRU +3%) after BAML upgrades to Buy and boosts the price target to $103 from $94.
    • The team views PRU's valuation as attractive after its sluggish start to the year - off 6% vs. a 1% increase in the median life name. There's also increased confidence the company can sustain an ROE above 14%, and a rising equity market means a lower cost of capital for the industry.
    • Noting PRU's status as a SIFI, BAML takes a conservative view towards buybacks, assuming just $500M over the next five quarters. "However, we would not be surprised if PRU continued its current $1B a year pace of buyback, which we believe would help support the ROE."
    • Others: MetLife (MET +2.1%), Lincoln National (LNC +2.2%), ING U.S. (VOYA +1.1%), Protective Life (PL +1.3%).
    | Comment!
  • Mar. 4, 2014, 4:33 PM
    • MetLife (MET) originated $3.3BN in agricultural loans in 2013, bringing its portfolio to more than $12B. Included in 2013's tally is $285M in loans to Brazilian crop producers, and the insurer is actively trying to drum up business in Canada, Australia, and New Zealand.
    • "Agricultural lending provides MetLife with investment opportunities that match the long-term liabilities the company writes through its insurance products."
    • Press release
    | Comment!
  • Feb. 23, 2014, 2:40 AM
    • MetLife (MET) will book a loss of $350-390M in Q1on the sale of a U.K. annuity unit to Rothesay Life.
    • MetLife expects the deal to close in Q2. Financial terms of the transaction weren't provided.
    | 1 Comment
  • Feb. 13, 2014, 11:56 AM
    • "Low rates and regulatory uncertainty present risks, but the risk-reward seems attractive given potential for ROE expansion, MetLife's (MET -0.5%) improving risk profile, and attractive valuation," says JPMorgan's Jimmy Bhullar, following last night's earnings report. He rates the stock at Overweight with $58 price target.
    • KBW's Jeffrey Schuman - who also has an Outperform, but with $64 price target - calculates core Q4 EPS at $1.40 (vs. $1.37 reported).
    • Credit Suisse's Tom Gallagher - who also rates the shares Outperform and with $59 price target - is pleased with Met's international results given the mixed reports from Prudential and Principal Financial earlier this earnings season." Looking ahead to Q1, we still think our $1.41 estimate looks good as we expect higher earnings from Corporate Benefit Funding from higher spread income to offset our expectation for some near-term follow-through softness in annuities and Group Benefits, both likely subdued by quarter to date equity markets and adverse seasonal mortality."
    • The company nearly doubled its quarterly dividend last year, but so far no buybacks while word is awaited from D.C. "We are not repurchasing shares at this time because we want to avoid the potential need to issue equity if there is an adverse regulatory outcome," says CEO Steve Kandarian on the earnings call.
    • Earlier coverage
    | Comment!
  • Feb. 13, 2014, 10:04 AM
    • Reiterating MetLife (MET -1.1%) as a top pick with $59 price target following last night's earnings, Scotiabank says the next catalysts for the stock - which gained 64% in 2013 - will be ROE expansion and regulatory developments.
    • "Do you think you're gaining traction with D.C.," an analyst asks CEO Steve Kandarian on the earnings call. "Still early days to make predictions," replies Kandarian, noting no SIFI designation has yet been made, but - for now - leverage will be kept at relatively low levels.
    | 1 Comment
  • Feb. 12, 2014, 4:23 PM
    • Operating earnings of $1.6B gained 14% Y/Y, with operating EPS of $1.37 up 10%. One-time adjustments for variable investment income, boosts to litigation reserves, and favorable catastrophe experience about cancelled each other out.
    • Americas operating earnings of $1.4B up 13%. Latin America of $173M up 17% (ProVida acquisition), Asia of $324M up 64% (unusually high investment income from Japan), EMEA of $89M up 51%.
    • Premiums of $13.1B -1% Y/Y. Book value per share (excl. AOCI) of $48.49 up 4% Y/Y.
    • CC tomorrow at 8 ET
    • Press release, Q4 results
    • MET +0.1% AH
    | Comment!
  • Feb. 12, 2014, 4:11 PM
    • MetLife, Inc. (MET): Q4 EPS of $1.37 beats by $0.07.
    • Revenue of $18.38B (+0.1% Y/Y) beats by $950M.
    • Press Release
    | Comment!
MET vs. ETF Alternatives
Company Description
MetLife Inc is a global provider of insurance, annuities & employee benefit programs in United States, Japan, Latin America, Asia, Europe & Middle East. It offers life insurance, annuities, property & casualty insurance, and other financial services.
Sector: Financial
Industry: Life Insurance
Country: United States